• Julia Corsetti

Clinical Trial Matching App for Patients with Metastatic Breast Cancer

Updated: Sep 30, 2019

This week, the Metastatic Breast Cancer Alliance (MBCA), the largest coalition of nonprofit breast cancer organizations, pharmaceutical/biotech companies, and patient advocates in the U.S., initiated a communications campaign to bring greater awareness and understanding of clinical trials to the metastatic breast cancer community in advance of the release of MBC Connect 2.0. MBC Connect is an interactive, web- and mobile-friendly patient experience registry that empowers patients in the U.S. to collaborate with researchers to advance metastatic breast cancer research, and with this new release will also potentially match patients with clinical trials.

After patients enter their demographic information and disease history into the app, MBC Connect 2.0 identifies potential clinical trial matches, thus avoiding the current, complex trial search process.  As users enter additional data, all of which is kept private and encrypted, more targeted clinical trial options are provided, increasing the likelihood of finding a clinical trial that the patient qualifies for while meeting the patient’s needs.

“Depending on an individual’s cancer diagnosis, a clinical trial may be an excellent treatment option,” said Shirley A. Mertz, a metastatic breast cancer patient and Chair of the Metastatic Breast Cancer Alliance (MBCA).  “As metastatic patients, we know that our current treatment will one day stop working, and we hope that another, more effective treatment, approved because of a successful clinical trial, will be available to us. The MBC Alliance’s launch of MBC Connect 2.0 makes it possible for every patient to easily identify trials that might be a fit for them and to be able to share those trials with their healthcare provider.”

MBCA is partnering with (BCT) and Quantum Leap Healthcare Collaborative, its parent organization, to enable clinical trial matching on MBC Connect. BCT sources its clinical trial data from, the US government’s official registry of clinical trials. To create accurate and patient-friendly results, BCT updates its data from on a daily basis, prepares trials for matching, writes patient-friendly summaries for each trial, and provides additional filters for narrowing match results. MBC Connect accesses the BCT/Quantum Leap Trial Matching Service via a secure connection.

MBC Connect 2.0 will soon be available on Android and iOS devices, and via web browser, in both English and Spanish, ensuring widespread availability for patients living with metastatic breast cancer in the U.S.

#breastcancer #clinicaltrials #nonprofit #mobileapp #android #ios

43 views0 comments